These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11213883)

  • 1. Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump.
    Kessler L; Tritschler S; Bohbot A; Sigrist S; Karsten V; Boivin S; Dufour P; Belcourt A; Pinget M
    Diabetes Care; 2001 Feb; 24(2):302-7. PubMed ID: 11213883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
    Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
    Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group.
    Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM. A multicenter study. The EVADIAC Study Group. Evaluation dans le Diabète du Traitement par Implants Actifs.
    Hanaire-Broutin H; Broussolle C; Jeandidier N; Renard E; Guerci B; Haardt MJ; Lassmann-Vague V
    Diabetes Care; 1995 Mar; 18(3):388-92. PubMed ID: 7555483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal delivery of insulin via mechanical pump: surgical implications.
    Udelsman R; Boyne MS; Loman KE; Saudek CD
    Langenbecks Arch Surg; 2000 Oct; 385(6):367-72. PubMed ID: 11127519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility.
    Renard E; Bouteleau S; Jacques-Apostol D; Lauton D; Gibert-Boulet F; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1996 Aug; 19(8):812-7. PubMed ID: 8842596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial of programmable implantable insulin pump for type I diabetes.
    Selam JL; Micossi P; Dunn FL; Nathan DM
    Diabetes Care; 1992 Jul; 15(7):877-85. PubMed ID: 1516508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical experience with implantable insulin pumps. Department of Veterans Affairs Implantable Insulin Pump Study Group.
    Thompson JS; Duckworth WC; Saudek CD; Giobbie-Hurder A
    Am J Surg; 1998 Dec; 176(6):622-6. PubMed ID: 9926802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic procedures for catheter malfunction in programmable implantable intraperitoneal insulin infusion devices.
    Olsen CL; Turner DS; Iravani M; Waxman K; Selam JL; Charles MA
    Diabetes Care; 1995 Jan; 18(1):70-6. PubMed ID: 7698051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term implantation of a new implantable programmable insulin pump in two diabetic dogs.
    Scavini M; Day PW; Eaton RP
    Artif Organs; 1992 Oct; 16(5):518-22. PubMed ID: 10078304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable insulin pumps: diagnosis and management of decreased flow rates using radionuclide investigation.
    Boulahdour H; Behar A; Haardt MJ; Selam JL
    Int J Artif Organs; 1996 Dec; 19(12):723-9. PubMed ID: 9029249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities and risks of insulin pump therapy].
    Renner R; Lüddeke HJ
    Internist (Berl); 1990 Mar; 31(3):226-35. PubMed ID: 2187830
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of antigenicity of Hoechst 21PH insulin using either implantable intraperitoneal pump or subcutaneous external pump infusion in type 1 diabetic patients.
    Jeandidier N; Boullu S; Busch-Brafin MS; Chabrier G; Sapin R; Gasser F; Pinget M
    Diabetes Care; 2002 Jan; 25(1):84-8. PubMed ID: 11772906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.